Understanding, diagnosing, and treating pancreatic cancer from the perspective of telomeres and telomerase
Open Access
- 9 April 2024
- journal article
- review article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 31 (9) , 1292-1305
Abstract
Telomerase is associated with cellular aging, and its presence limits cellular lifespan. Telomerase by preventing telomere shortening can extend the number of cell divisions for cancer cells. In adult pancreatic cells, telomeres gradually shorten, while in precancerous lesions of cancer, telomeres in cells are usually significantly shortened. At this time, telomerase is still in an inactive state, and it is not until before and after the onset of cancer that telomerase is reactivated, causing cancer cells to proliferate. Methylation of the telomerase reverse transcriptase (TERT) promoter and regulation of telomerase by lactate dehydrogenase B (LDHB) is the mechanism of telomerase reactivation in pancreatic cancer. Understanding the role of telomeres and telomerase in pancreatic cancer will help to diagnose and initiate targeted therapy as early as possible. This article reviews the role of telomeres and telomerase as biomarkers in the development of pancreatic cancer and the progress of research on telomeres and telomerase as targets for therapeutic intervention.Keywords
This publication has 155 references indexed in Scilit:
- Phosphorylation of hTERT at threonine 249 is a novel tumor biomarker of aggressive cancer with poor prognosis in multiple organsThe Journal of Pathology, 2022
- Pancreatic CancerJAMA, 2021
- Pancreatic cancer—A disease in need: Optimizing and integrating supportive careCancer, 2019
- Genetic determinants of telomere length and risk of pancreatic cancer: A PANDoRA studyInternational Journal of Cancer, 2018
- Essential roles of telomerase reverse transcriptase hTERT in cancer stemness and metastasisFEBS Letters, 2018
- GOLPH3 induces epithelial–mesenchymal transition via Wnt/β‐catenin signaling pathway in epithelial ovarian cancerCancer Medicine, 2017
- A highly sensitive and quantitative telomerase activity assay with pancreatic juice is useful for diagnosis of pancreatic carcinoma without problems due to polymerase chain reaction inhibitorsCancer, 2004
- Telomerase activity of cultured human pancreatic carcinoma cell lines correlates with their potential for migration and invasionCancer, 2001
- Somatic genetic alterations inBRCA2-associated and sporadic male breast cancerGenes, Chromosomes and Cancer, 1999
- Further evidence for a non‐random chromosomal abnormality in acute promyelocytic leukemiaInternational Journal of Cancer, 1977